Xiaojiang Zhan

1.2k citations
65 papers · 844 indexed · h-index 15
Topics
Dialysis and Renal Disease Management (33 papers)Inflammatory Biomarkers in Disease Prognosis (11 papers)Blood Pressure and Hypertension Studies (8 papers)

In The Last Decade

Xiaojiang Zhan

60 papers receiving 829 citations

Peers

Xiaojiang Zhan
Comparison fields: 5 of 77
  • Nephrology 232
  • Immunology 226
  • Rheumatology 197
  • Surgery 140
  • Epidemiology 123
Replace Jung Soo Song with:
Jung Soo Song South Korea
Armando Gabrielli Italy
Hernán Trimarchi Argentina
Yu‐Jr Lin Taiwan
Sagrario Soriano Spain
Tetsuya Mitarai Japan
Stephanie Keeling Canada
Tung‐Po Huang Taiwan
D. Marchesi Italy
Qinghua Liu China
Xiaojiang Zhan relative to Jung Soo Song South Korea Jung Soo Song's profile →
Citations per field
00.5×3.2×
Jung Soo Song · 1×
Citations per year

Countries citing papers authored by Xiaojiang Zhan

Since Specialization
Citations

This map shows the geographic impact of Xiaojiang Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojiang Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojiang Zhan more than expected).

Fields of papers citing papers by Xiaojiang Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojiang Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojiang Zhan. The network helps show where Xiaojiang Zhan may publish in the future.

Co-authorship network of co-authors of Xiaojiang Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojiang Zhan. A scholar is included among the top collaborators of Xiaojiang Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojiang Zhan. Xiaojiang Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 3
5 1
6 8
7 13
8 2
9 1
10 6
11 8
12 4
13 16
14 2
15 8
16 25
17 2
18 1
19 215
20 6

About Xiaojiang Zhan

Xiaojiang Zhan is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Emergency Medical Services, having authored 65 papers that have together received 844 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (33 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers) and Blood Pressure and Hypertension Studies (8 papers). The work is most often cited by research in Nephrology (232 citations), Rheumatology (197 citations) and Immunology (226 citations). Xiaojiang Zhan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoran Feng, Yueqiang Wen, Xianfeng Wu, Jeffrey Crowley, C. Birbara, Christopher J Edwards, Janusz Jaworski, Francisco J. Blanco, Paul Bird and Jacob Aelion. Their work appears in journals such as Gastroenterology, PLoS ONE and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026